Marco D'Agata
AeroLeads people directory · profile

Marco D'Agata Email & Phone Number

CEO and Founder at Neolook Solutions
Location: Hilversum, North Holland, Netherlands 7 work roles 3 schools
1 work email found @neolooksolutions.com LinkedIn matched
✓ Verified Jul 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email m****@neolooksolutions.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
CEO and Founder
Location
Hilversum, North Holland, Netherlands
Company size

Who is Marco D'Agata? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Marco D'Agata is listed as CEO and Founder at Neolook Solutions, a with 15 employees, based in Hilversum, North Holland, Netherlands. AeroLeads shows a work email signal at neolooksolutions.com and a matched LinkedIn profile for Marco D'Agata.

Marco D'Agata previously worked as CEO & Founder at Neolook Solutions and Senior Strategic Business Architect EMEA at Philips. Marco D'Agata holds Master, Biomedical Sciences from Universiteit Utrecht.

Company email context

Email format at Neolook Solutions

This section adds company-level context without repeating Marco D'Agata's masked contact details.

{first}.{last}@neolooksolutions.com
89% confidence

AeroLeads found 1 current-domain work email signal for Marco D'Agata. Compare company email patterns before reaching out.

Profile bio

About Marco D'Agata

Opens doors that remain closed to most of us.Makes the unsuspected, the unlikely happen.

Listed skills include Funding, New Business Development, Public Speaking, Healthcare, and 17 others.

Current workplace

Marco D'Agata's current company

Company context helps verify the profile and gives searchers a useful next step.

Neolook Solutions
Neolook Solutions
CEO and Founder
Utrecht, UT, NL
Employees
15
AeroLeads page
7 roles · 28 years

Marco D'Agata work experience

A career timeline built from the work history available for this profile.

Ceo & Founder

Current

Utrecht, Netherlands

✭✭✭ Winner Life Science Innovation Award 2024✭✭✭ Honorable visit to Máxima MC by his majesty King Willem Alexander of the Netherlands✭✭✭ Finalist National Healthcare Innovation Award 2024✭✭✭ Qualio Winner Catalyst Life Science Award (global)✭✭✭ 1st Place Dutch Computable Awards 2023 ('Oscar of IT awards in NL')✭✭✭ Featured in De Medisch Specialist 2022 (30.000 copies)✭✭✭ Finalist Dutch Student Innovation Award 2022 (115 submissions)✭✭✭ Winner EU Bridgehead 2021✭✭✭ Finalist UK Healthtech Awards 2021✭✭✭ Featured Dutch AD newspaper, Tokyo News TVMedical grade video services for love, attention and clinical understanding in neonatal and pediatric intensive careS2S Family - Watch your newborn in the NICU from home, share live with partner, sibs and extended family. Simple, Secure and Safe with privacy by design (EU standards).S2S Academic - Extend to academic research, develop clinical algorithms and AI. S2S Professional - Line of Sight, Alarm mgt, Event Capture, Remote Consultation, Integrations.With add-ons: Neolook One smart sensor, Cry Detection, Benefit Tracking, EarlyMoves.explore https://www.neolooksolutions.com

Jan 2020 - Present

Senior Strategic Business Architect Emea

Netherlands

✭✭✭ "One of the coolest jobs in Philips" - Human Resources✭✭✭ Fatebenefratelli NICU solution on TG1 national news in Italy✭✭✭ NICU Solution in Dutch newspaper of record NRC, two page background articleI. Team Lead of Strategic Business Architects EMEA/LATAM Lead of Strategic Business Architects global community of practiceII. Lead the solution design of complex, innovative solutions covering the full continuum of care, using Value Based Care and Philips Quadrupal Aim. Grow Philips integrated solutions business. Drive the creation of groundbreaking solutions in Europe, the Middle East, Africa and Latin America. Realize first-of-a-kind deals and make replicable elsewhere.With a peculiar focus on Value Based Care (#VBC), Philips' Quadrupal Aim, the clinical perspective and #reimbursement.III. Bring together and grow the Strategic Business Architect Community in markets worldwide. With high quality solutions content, develop and share best practices, on the fly cross-market learning on deals as they happen, with the aim of global professionalization and scalability.Example Solutions / Longterm Strategic Partnerships- Neonatal Intensive Care Unit (NICU) modernization in Italy (National News TV, NRC)- Design of healthcare ecosystem at regional scale in Nordics- Ring of sustainable referral hospitals at national scale in Africa- Medical City with data analytics, data science and adaptive intelligence in Middle EastRoyal Philips is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care.

Aug 2015 - Dec 2019

Senior Strategy And Policy Deployment For High Cost Medicine

Leiden

✭✭✭ 2018 Hospital made high cost medicines - national TV 8 o’clock news, NOS✭✭✭ 2015, 2018 Initatiefgroep Biosimilars Nederland - national TV news, NOS✭✭✭ 2014 Impact Collective Farma - national 8 o'clock TV news, frontpage FD, NOSAchmea, the nr 1 healthcare insurer, covers 30% of the population and contracts EUR 700-900 million of specialty pharmacy a year. A dedicated team was set up to anticipate major shifts and prevent high cost medicines (biologicals) spiralling out of control. Thereby safeguarding solidarity, sustainable affordable care and access for all. Achievements 2012-2015I. Impact Collective FarmaDesign and introduction of a formerly unseen market mechanism for group procurement (gezamenlijke inkoop) of high cost medicines. The collective was formed by 20 hospitals and Achmea adding up to 30-35% of the national volume. Benefits are shared in three thirds to hospitals, consumers and an innovation agenda. IC Farma deeply impacted and transformed the national market landscape of EUR 1,5 billion annualy.II. Initatiefgroep Biosimilars Nederland (IBN)Design and introduction of a novel scheme to further the uptake of biosimilars: IBN is a content and knowledge driven group to develop and disseminate key knowledge, educate professionals and public, and challenge policies and standpoints. IBN was designed in 2013, started in 2014 and had it’s first national symposium in september 2015.III. Hospital made high cost medicinesSeven key farma innovations were selected in an overarching disruption framework and funneled to market. The aim is a supply chain that is end-user driven and responsive to societal needs. The seven included 25% dose reduction, biosimilars, MedEye, and deep impact ones like hospital production of Rhenium, biologicals recycling and the seminal realisation of ‘short chain pharma' for hospital production of orphan drugs: magistrale bereiding with AMC.

Apr 2012 - Aug 2015

Senior Innovation, Acquisition, And Market Development

Dutch Institute For Rational Use Of Medicine

Utrecht Area, Netherlands

✭✭✭ National Healthcare Innovation Award ✭✭✭ Logica Innovation AwardCounselor to CEO, management team and program managers. Develop novel projects, funding and strategic collaborations.Examples: Prescription practices, Antibiotics & Resistance, International collaboration on rational use of medicin, Pharma chain development, Start & Stop apps (antidepressants, lungmedication, antibiotics, ADHD), Medication Safety, Healthcare for immigrants, Patient Empowerment, Immigrants, Improving the hospital patient status registration standards on pharmacotherapy.

Jan 2003 - Jun 2012

Pertussis Vaccin Trial In Newborns, Bioterrorism

Bilthoven

GCP qualified project employee for Phase III clinical trial on newborns for a new pertussis (whooping cough) vaccine. A highly sensitive project under public attention. Knowledge management for central and field professionals, including central support, registration of adverse events (AE) and serious adverse events (SAE). Worked on bioterrorism threats and national responses, in particular on smallpox. Since smallpox officially had been eradicated, the population gradually lost it's immunity making it vulnerable to an outbreak. Developed in 'stealth mode'.

Jun 2000 - Jun 2001

Developer New Study Of Medicine At Utrecht University

Universitair Medisch Centrum Utrecht

Utrecht Area, Netherlands

Project employee for the full scale modernization of the 6 year study of Medicine at Utrecht University.

1999 - 2000 ~1 yr
3 education records

Marco D'Agata education

Master, Biomedical Sciences

Activities and Societies: 1st elected member of the Council for the Faculty of Medicine - Chairman Taskforce Interfaculty Committee.

Bachelor’S Degree, Biochemistry And Molecular Biology, Microbiology

Rijkshogeschool Ijselland Deventer

Activities and Societies: Research and thesis on hypertrophic cardiomyopathy, Institute for Biology and Genetics, Genoa, Italy 1993/1994

FAQ

Frequently asked questions about Marco D'Agata

Quick answers generated from the profile data available on this page.

What company does Marco D'Agata work for?

Marco D'Agata works for Neolook Solutions.

What is Marco D'Agata's role at Neolook Solutions?

Marco D'Agata is listed as CEO and Founder at Neolook Solutions.

What is Marco D'Agata's email address?

AeroLeads has found 1 work email signal at @neolooksolutions.com for Marco D'Agata at Neolook Solutions.

Where is Marco D'Agata based?

Marco D'Agata is based in Hilversum, North Holland, Netherlands while working with Neolook Solutions.

What companies has Marco D'Agata worked for?

Marco D'Agata has worked for Neolook Solutions, Philips, Achmea, Dutch Institute For Rational Use Of Medicine, and Rivm National Institute For Public Health And The Environment.

How can I contact Marco D'Agata?

You can use AeroLeads to view verified contact signals for Marco D'Agata at Neolook Solutions, including work email, phone, and LinkedIn data when available.

What schools did Marco D'Agata attend?

Marco D'Agata holds Master, Biomedical Sciences from Universiteit Utrecht.

What skills is Marco D'Agata known for?

Marco D'Agata is listed with skills including Funding, New Business Development, Public Speaking, Healthcare, Project Management, Proposal Writing, Pharmacy, and Medicine.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.

People with similar names

Check these profiles if this is not the Marco D'Agata you were looking for.

View similar profiles